Search Page

1

Cite

Share

Long-term follow-up of the West of Scotland Coronary Prevention Study.

Ford I, Murray H, Packard CJ, Shepherd J, Macfarlane PW, Cobbe SM; West of Scotland Coronary Prevention Study Group. Ford I, et al. N Engl J Med. 2007 Oct 11;357(15):1477-86. doi: 10.1056/NEJMoa065994. N Engl J Med. 2007. PMID: 17928595 Free article. Clinical Trial.

Cite

Share

2

Cite

Share

The West of Scotland coronary prevention study: economic benefit analysis of primary prevention with pravastatin.

Caro J, Klittich W, McGuire A, Ford I, Norrie J, Pettitt D, McMurray J, Shepherd J. Caro J, et al. Among authors: ford i. BMJ. 1997 Dec 13;315(7122):1577-82. doi: 10.1136/bmj.315.7122.1577. BMJ. 1997. PMID: 9437275 Free PMC article. Clinical Trial.

Cite

Share

3

Cite

Share

International economic analysis of primary prevention of cardiovascular disease with pravastatin in WOSCOPS. West of Scotland Coronary Prevention Study.

Caro J, Klittich W, McGuire A, Ford I, Pettitt D, Norrie J, Shepherd J. Caro J, et al. Among authors: ford i. Eur Heart J. 1999 Feb;20(4):263-8. doi: 10.1053/euhj.1999.1193. Eur Heart J. 1999. PMID: 10099920

Cite

Share

4

Cite

Share

Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in the West of Scotland Coronary Prevention Study.

Freeman DJ, Norrie J, Sattar N, Neely RD, Cobbe SM, Ford I, Isles C, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, Shepherd J, Gaw A. Freeman DJ, et al. Among authors: ford i. Circulation. 2001 Jan 23;103(3):357-62. doi: 10.1161/01.cir.103.3.357. Circulation. 2001. PMID: 11157685 Clinical Trial.

Cite

Share

5

Cite

Share

Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.

Simes J, Furberg CD, Braunwald E, Davis BR, Ford I, Tonkin A, Shepherd J. Simes J, et al. Among authors: ford i. Eur Heart J. 2002 Feb;23(3):207-15. doi: 10.1053/euhj.2001.2775. Eur Heart J. 2002. PMID: 11792135 Clinical Trial.

Cite

Share

6

Cite

Share

C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study.

Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N; West of Scotland Coronary Prevention Study. Freeman DJ, et al. Among authors: ford i. Diabetes. 2002 May;51(5):1596-600. doi: 10.2337/diabetes.51.5.1596. Diabetes. 2002. PMID: 11978661

Cite

Share

7

Cite

Share

The cardiovascular event reduction tool (CERT)--a simplified cardiac risk prediction model developed from the West of Scotland Coronary Prevention Study (WOSCOPS).

L'Italien G, Ford I, Norrie J, LaPuerta P, Ehreth J, Jackson J, Shepherd J. L'Italien G, et al. Among authors: ford i. Am J Cardiol. 2000 Mar 15;85(6):720-4. doi: 10.1016/s0002-9149(99)00847-4. Am J Cardiol. 2000. PMID: 12000046

Cite

Share

8

Cite

Share

The role of covariates in estimating treatment effects and risk in long-term clinical trials.

Ford I, Norrie J. Ford I, et al. Stat Med. 2002 Oct 15;21(19):2899-908. doi: 10.1002/sim.1294. Stat Med. 2002. PMID: 12325106 Review.

Cite

Share

9

Cite

Share

Factors affecting low-density lipoprotein and high-density lipoprotein cholesterol response to pravastatin in the West Of Scotland Coronary Prevention Study (WOSCOPS).

Streja L, Packard CJ, Shepherd J, Cobbe S, Ford I; WOSCOPS Group. Streja L, et al. Among authors: ford i. Am J Cardiol. 2002 Oct 1;90(7):731-6. doi: 10.1016/s0002-9149(02)02599-7. Am J Cardiol. 2002. PMID: 12356386

Cite

Share

10

Cite

Share

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Shepherd J, et al. Among authors: ford i. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x. Lancet. 2002. PMID: 12457784 Clinical Trial.

Cite

Share